Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The pathogenesis of sporadic
amyotrophic lateral sclerosis
(
ALS
) remains unknown. Neurophysiological studies provide evidence of hyperexcitability of the motor cortex or of impairment of inhibitory intrahemispheric modulation of the corticomotoneuron in
ALS
. In this paper, we used
TMS
to elicit transcallosal inhibition of the motor cortex in
ALS
patients in order to investigate whether interhemispheric inhibitory mechanisms subserved by callosal fibres are also disturbed in
ALS
. Twenty-five patients with
ALS
and 18 controls were recruited for the study. Resting Motor Threshold (RMT), Silent Period (SP) and interhemispheric inhibition (IHI) were recorded. No significant difference was detected regarding RMT or the duration of SP between patients and controls. IHI was detected in all controls. IHI was totally absent in eight patients, in another eight patients IHI did not reach a significant level and in the remaining nine patients was normal. The degree of IHI was significantly lower in
ALS
patients than in controls (p = 0.001). In conclusion, altered IHI in
ALS
patients is in line with the general pattern of reduced corticomotoneuron inhibition, being thus, one of the factors which may lead to chronic overexcitation of pyramidal cells.
...
PMID:Impaired interhemispheric inhibition in amyotrophic lateral sclerosis. 1745 40